The possible molecular basis for the previously described antagonistic inte
ractions between adenosine A(1) receptors (A(1)R) and dopamine D-1 receptor
s (D1R) in the brain have been studied in mouse fibroblast Ltk(-) cells cot
ransfected with human A(1)R and D1R cDNAs or with human A(1)R and dopamine
D-2 receptor (long-form) (D2R) cDNAs and in cortical neurons in culture. A(
1)R and D1R, but not A(1)R and D2R, were found to coimmunoprecipitate in co
transfected fibroblasts. This selective A(1)R/D1R heteromerization disappea
red after pretreatment with the D1R agonist, but not after combined pretrea
tment with D1R and A(1)R agonists. A high degree of A(1)R and D1R colocaliz
ation, demonstrated in double immunofluorescence experiments with confocal
laser microscopy, was found in both cotransfected fibroblast cells and cort
ical neurons in culture. On the other hand, a low degree of A(1)R and D2R c
olocalization was observed in cotransfected fibroblasts. Pretreatment with
the A(1)R agonist caused coclustering (coaggregation) of A(1)R and D1R. whi
ch was blocked by combined pretreatment with the D1R and A(1)R agonists in
both fibroblast cells and in cortical neurons in culture. Combined pretreat
ment with D1R and A(1)R agonists, but not with either one alone, substantia
lly reduced the D1R agonist-induced accumulation of cAMP. The A(1)R/D1R het
eromerization may be one molecular basis for the demonstrated antagonistic
modulation of A(1)R of D1R receptor signaling in the brain. The persistence
of A(1)R/D1R heteromerization seems to be essential for the blockade of A(
1)R agonist-induced A(1)R/D1R coclustering and for the desensitization of t
he D1R agonist-induced cAMP accumulation seen on combined pretreatment with
D1R and A(1)R agonists, which indicates a potential role of A(1)R/D1R hete
romers also in desensitization mechanisms and receptor trafficking.